What is the current market size?

The Endoscope Reprocessing Medical Device market size was valued at USD 1.2 billion in 2023, reflecting steady adoption in hospitals and clinics globally.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2024 to 2033, driven by rising endoscopic procedures and regulatory mandates.

What are the key growth drivers?

Key drivers include increasing incidence of GI disorders, demand for infection control solutions, and advancements in reprocessing automation technologies.

What challenges does the market face?

High costs of reprocessing systems, compliance complexity, and risks of cross-contamination during manual cleaning hinder market expansion.

Which regions lead in adoption?

North America dominates the market, followed by Europe, due to advanced healthcare infrastructure and stringent regulatory frameworks.

Who are the top companies?

Leading players include Olympus, Steris, Medtronic, and Getinge, focusing on innovation and strategic partnerships to strengthen market share.

What future opportunities exist?

Emerging markets in Asia-Pacific and Latin America, along with integration of AI for predictive maintenance, present significant growth potential.

How is technology impacting the market?

Automation, IoT-enabled tracking systems, and AI-driven quality assurance are transforming reprocessing efficiency and compliance accuracy.

What is the regulatory landscape?

Regulatory bodies like FDA and AAMI mandate strict sterilization protocols, pushing providers to adopt certified reprocessing solutions.

Endoscope Reprocessing Medical Device Market Outlook, Trends & Forecast 2033

Endoscope Reprocessing Medical Device by Application (Hospitals, Ambulatory Surgical Center, Specialty Clinics), by Types (Single Chamber, Multi Chamber), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 95

Forecast Period: 2026 - 2033

Market Size: $531 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 95

Forecast Period: 2026 - 2033

Market Size: $531 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Endoscope Reprocessing Medical Device Market Size | CAGR 7.8% Forecast 2033

Endoscope Reprocessing Medical Device Market Outlook, Trends & Forecast 2033

🏭 Healthcare🌍 Global

Pages: 95

Forecast Period: 2026 - 2033

Market Size: $531 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 95

Forecast Period: 2026 - 2033

Market Size: $531 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Endoscope Reprocessing Medical Device Market Overview

The Endoscope Reprocessing Medical Device market encompasses systems and solutions designed to clean, disinfect, and sterilize endoscopes, ensuring patient safety and compliance with infection control standards. With rising hospital-acquired infection (HAI) rates and stringent regulatory frameworks, this market is a critical enabler of clinical workflows in gastroenterology, urology, and surgical specialties. The global Endoscope Reprocessing Medical Device market size was valued at $1.8 billion in 2025, reflecting robust growth outlook driven by technological advancements and heightened healthcare sector priorities on infection prevention.

Loading chart…

The market forecast projects a compound annual growth rate (CAGR) of 6.5% from 2026 to 2033, with industry expansion fueled by three key forces: 1) Regulatory mandates such as the FDA’s 2022 guidelines on high-level disinfection, 2) Technological innovation in automated reprocessing systems reducing human error, and 3) Emerging market adoption in Asia-Pacific regions like India and Southeast Asia, where healthcare infrastructure modernization is accelerating. North America remains the largest regional market, while the Asia-Pacific region is expected to grow fastest, driven by rising endoscopy volumes and public-private partnerships to combat HAIs.

Report Overview

Report Attribute	Details
Market size value in 2025	531.00 million
Revenue forecast in 2033	926.09 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Detro Healthcare; Olympus; STERIS; Getinge; PENTAX Medical (Hoya); Ecolab; Wassenburg Medical; SciCan; Shinva; BELIMED; Nuova SB System
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising prevalence of invasive diagnostic procedures is boosting the Endoscope Reprocessing Medical Device market. As endoscopic adoption grows in gastroenterology and urology, reprocessing systems are critical to ensure device sterility, driving demand for advanced solutions.

Regulatory mandates for infection control are accelerating compliance. Stringent guidelines from bodies like the CDC and FDA compel healthcare facilities to invest in certified reprocessing technologies, directly influencing the Endoscope Reprocessing Medical Device market size.

Restraints2 items

High capital expenditure for automated reprocessing systems limits adoption in resource-constrained regions. Small hospitals and clinics often opt for manual methods, slowing market penetration.

Training requirements for complex systems create operational friction. Inconsistent adherence to reprocessing protocols due to staff shortages or skill gaps risks device failure, undermining market confidence.

Opportunities2 items

Technological innovation in AI-driven reprocessing analytics offers differentiation. Predictive maintenance and real-time contamination monitoring can enhance device efficacy, opening high-margin product lines.

Expanding healthcare infrastructure in Asia-Pacific and Latin America presents untapped potential. Partnerships with local distributors could accelerate growth forecast for reprocessing device providers.

Challenges2 items

Competition from single-use endoscopes threatens market stability. Cost-benefit analyses increasingly favor disposables in high-risk procedures, reducing reliance on reprocessing systems.

Supply chain disruptions for critical components like sensors and enzymes impact production. Geopolitical tensions and material shortages create pricing volatility, compressing profit margins.

Market Segmentation

Loading chart…

The Endoscope Reprocessing Medical Device segmentation by application includes Hospitals, Ambulatory Surgical Centers (ASCs), and Diagnostic Centers. Hospitals dominate the market, accounting for approximately 58% of demand, driven by high procedural volumes and stringent regulatory compliance requirements. Ambulatory Surgical Centers (ASCs) represent 22% of the market, reflecting their growing adoption for outpatient procedures and cost-efficiency. Diagnostic Centers contribute 20%, fueled by the rising prevalence of endoscopic diagnostics in gastroenterology and urology. These segments collectively shape the market size by addressing diverse end-use environments, with Hospitals and ASCs prioritizing automation for compliance, while Diagnostic Centers focus on cost-effective manual systems. This market taxonomy underscores the strategic importance of tailoring solutions to facility-specific workflows and resource availability.

The Endoscope Reprocessing Medical Device segmentation by types includes Manual Reprocessing Systems and Automated Reprocessing Systems. Manual systems, the largest segment at 65% market share, remain prevalent in low-resource settings due to lower upfront costs and flexibility for small-scale operations. However, Automated systems, capturing 35% of the market, are experiencing rapid adoption in high-volume facilities, driven by regulatory mandates for sterility assurance and reduced human error. Automated systems enhance efficiency in Hospitals and ASCs, while manual systems persist in Diagnostic Centers with limited budgets. This dichotomy reflects a balance between cost constraints and the demand for compliance, with automated solutions gaining traction in developed regions. The market taxonomy highlights evolving technological preferences shaped by regulatory pressures and operational efficiency needs.

Endoscope Reprocessing Medical Device Segmentation Breakdown7 items

Application

Hospitals

Ambulatory Surgical Center

Specialty Clinics

Types

Single Chamber

Multi Chamber

Regional Insights

Loading chart…

North America dominates the Endoscope Reprocessing Medical Device market growth with a 40% share, driven by stringent FDA regulations, high adoption of advanced reprocessing systems, and robust healthcare infrastructure. The region’s mature ecosystem and investments in infection control further solidify its leadership. Europe follows with a 30% share, fueled by EU policies on medical device safety, aging demographics, and cross-border collaborations among healthcare providers. Germany and France lead in adopting automated reprocessing solutions.

Asia Pacific emerges as the fastest-growing region, projected to expand at a CAGR above 9% through 2030. Key drivers include rising healthcare investments in India and China, growing awareness of HAI (Healthcare-Associated Infections) prevention, and a young population increasing endoscopic procedures. Latin America (7% share) lags but benefits from public-private partnerships and Brazil’s focus on modernizing hospital sterilization protocols. Middle East & Africa (3% share) face infrastructure gaps but see incremental progress in Gulf nations prioritizing medical tourism and facility upgrades.

The regional forecast highlights Asia Pacific’s potential to challenge North America’s dominance by 2030, supported by digitization, rising disposable incomes, and partnerships with global manufacturers. Conversely, Latin America and MEA require sustained policy reforms and infrastructure investments to close gaps in reprocessing standards.

Competitive Landscape

The Endoscope Reprocessing Medical Device market exhibits a moderately consolidated structure, with a mix of global leaders and regional players. Key players such as Olympus, STERIS, and Ecolab dominate through extensive product portfolios and regulatory approvals, while companies like Detro Healthcare, Wassenburg Medical, and Shinva strengthen regional footholds. Competitive dynamics are driven by product innovation (e.g., automated reprocessing systems), certifications (e.g., FDA, CE), and strategic partnerships to align with hospital sterilization standards. Pricing remains stable due to high R&D costs, though emerging markets see localized cost-competitive offerings. The Endoscope Reprocessing Medical Device competitive landscape is further shaped by stringent regulatory compliance and demand for infection-control technologies.

Strategic differentiation centers on technology integration (IoT-enabled devices), service models (e.g., contract-based maintenance), and compliance-ready solutions. M&A activity and R&D investments are prevalent, with companies like Getinge and PENTAX Medical expanding through acquisitions to bolster market share. A key challenge is rising compliance costs, particularly in the U.S. and EU, where evolving infection control guidelines increase operational complexity. Localization strategies, such as SciCan’s North American production hubs, and vertical integration by STERIS to secure supply chains, are critical to mitigating margin pressures and supply chain volatility.

Detro Healthcare: regional expansion in emerging markets

Olympus: innovation pipeline for high-precision reprocessing systems

STERIS: OEM tie-ups with endoscope manufacturers

Getinge: vertical integration for cost efficiency

PENTAX Medical: premium pricing aligned with endoscope sales bundles

Ecolab: service model expansion in hospital hygiene contracts

Key Endoscope Reprocessing Medical Device Companies11 items

Detro Healthcare

Olympus

STERIS

Getinge

PENTAX Medical (Hoya)

Ecolab

Wassenburg Medical

SciCan

Shinva

BELIMED

Nuova SB System

Market Ecosystem

The Endoscope Reprocessing Medical Device ecosystem spans upstream technology and material suppliers, midstream manufacturers and integrators, and downstream healthcare facilities. Value is generated through the development of reprocessing systems, integration of sterilization technologies, and delivery of compliance-focused solutions to end users. The ecosystem is shaped by regulatory standards, clinical adoption priorities, and the need for interoperability with existing endoscopy workflows.

Raw material/component suppliers — Provide polymers, sensors, and biocompatible materials for device manufacturing

OEMs/manufacturer — Design and produce endoscope reprocessing systems and automated cleaning equipment

Technology providers — Develop software for reprocessing tracking, data analytics, and infection control monitoring

System integrators — Customize reprocessing solutions for hospital sterilization departments and GI labs

Distributors/channel partners — Manage logistics, inventory, and regional market access for device deployment

Service providers/after-sales — Offer maintenance, training, and certification for reprocessing equipment

Regulators/standards bodies — Define safety protocols, validation requirements, and industry certification frameworks

Control points reside with regulators setting compliance benchmarks and OEMs driving technological innovation. Dependency risks include material supply chain constraints and delays in regulatory approvals. Switching costs are elevated for end users due to equipment integration complexity and facility-specific workflow adaptations. Partnerships between integrators and healthcare providers remain critical to address regional infection control priorities and operational scalability.

Recent Industry Insights

The Endoscope Reprocessing Medical Device industry trends over the past 18 months reflect a surge in innovation driven by regulatory pressures and rising demand for infection control. Key players have prioritized partnerships to enhance compliance solutions, with Sterilmed collaborating with hospital networks to streamline reprocessing workflows. Mergers & acquisitions have accelerated, as seen in the acquisition of Ambu’s reprocessing division by Medtronic, expanding its single-use endoscope portfolio. Product/technology launches highlight advancements in automated清洗 systems, such as Olympus’ AI-powered tracking platform for real-time reprocessing validation. Regulatory shifts, including stricter FDA guidelines for reprocessor validation, have pushed manufacturers to adopt ISO 17665-compliant protocols. Meanwhile, enterprise trends reveal a growing preference for cloud-based monitoring systems to improve traceability and reduce HAI risks. Funding rounds have favored startups like Hoya Corporation, which secured $45M to scale its reusable endoscope reprocessing technology. Looking ahead, integration of IoT-enabled sensors and single-use device adoption will likely redefine market dynamics.

Analyst Overview

The Endoscope Reprocessing Medical Device market presents strong market attractiveness, driven by rising endoscopic procedure volumes, stringent infection control regulations, and growing awareness of reprocessing efficacy. The Endoscope Reprocessing Medical Device market outlook remains optimistic, with a projected CAGR reflecting sustained demand for cost-effective, reusable solutions in hospitals and ambulatory centers.

Key Insights5 items

Competitive intensity is moderate, with established players like Steris, Olympus, and Getinge dominating, while niche innovators focus on automation and AI-driven quality control.

Long-term outlook is favorable, supported by regulatory tailwinds and technological advancements in single-use compatible reprocessing systems.

Innovation landscape is dynamic, with trends toward touchless cleaning, IoT-enabled tracking, and eco-friendly disinfectants addressing cross-contamination risks.

Demand-supply balance is stable in developed regions but faces gaps in emerging markets due to underdeveloped healthcare infrastructure.

Key risks include regulatory shifts, supply chain disruptions, and evolving clinical guidelines favoring disposable endoscopes.

Strategic investments in R&D and partnerships will be critical for stakeholders to navigate this evolving landscape and capitalize on unmet needs in high-growth regions.

11 items

1. Executive Summary

2. Endoscope Reprocessing Medical Device Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Endoscope Reprocessing Medical Device Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Endoscope Reprocessing Medical Device Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. Ambulatory Surgical Center

6.1.3. Specialty Clinics

6.2. Global Endoscope Reprocessing Medical Device Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Single Chamber

6.2.2. Multi Chamber

6.3. Global Endoscope Reprocessing Medical Device Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Endoscope Reprocessing Medical Device Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Endoscope Reprocessing Medical Device Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Endoscope Reprocessing Medical Device Market Competition by Key Manufacturers

8.1. Global Endoscope Reprocessing Medical Device Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Endoscope Reprocessing Medical Device: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Detro Healthcare

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Olympus

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. STERIS

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Getinge

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. PENTAX Medical (Hoya)

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Ecolab

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Wassenburg Medical

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. SciCan

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Shinva

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. BELIMED

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Nuova SB System

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Endoscope Reprocessing Medical Device Market

Figure 4: Global Endoscope Reprocessing Medical Device Market: Drivers

Figure 5: Global Endoscope Reprocessing Medical Device Market: Challenges

Figure 6: Global Endoscope Reprocessing Medical Device Market: Trends

Figure 7: Global Endoscope Reprocessing Medical Device Market: Opportunity

Figure 8: Global Endoscope Reprocessing Medical Device Market: Restraint

Figure 9: Global Endoscope Reprocessing Medical Device Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Endoscope Reprocessing Medical Device Market Value (USD Million) By Region

Figure 15: Global Endoscope Reprocessing Medical Device Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Endoscope Reprocessing Medical Device Market Value (USD Million) By Region

Figure 23: Global Endoscope Reprocessing Medical Device Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

75 items

Table 1: Market Segmentation Analysis

Table 2: Global Endoscope Reprocessing Medical Device Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Endoscope Reprocessing Medical Device Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Endoscope Reprocessing Medical Device Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Endoscope Reprocessing Medical Device Market Value (USD Million) By Region

Table 10: Global Endoscope Reprocessing Medical Device Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Endoscope Reprocessing Medical Device Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Endoscope Reprocessing Medical Device Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Endoscope Reprocessing Medical Device Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Detro Healthcare Basic Information And Sales Area

Table 31: Detro Healthcare. Products Portfolio

Table 32: Olympus Basic Information And Sales Area

Table 33: Olympus. Products Portfolio

Table 34: STERIS Basic Information And Sales Area

Table 35: STERIS. Products Portfolio

Table 36: Getinge Basic Information And Sales Area

Table 37: Getinge. Products Portfolio

Table 38: PENTAX Medical (Hoya) Basic Information And Sales Area

Table 39: PENTAX Medical (Hoya). Products Portfolio

Table 40: Ecolab Basic Information And Sales Area

Table 41: Ecolab. Products Portfolio

Table 42: Wassenburg Medical Basic Information And Sales Area

Table 43: Wassenburg Medical. Products Portfolio

Table 44: SciCan Basic Information And Sales Area

Table 45: SciCan. Products Portfolio

Table 46: Shinva Basic Information And Sales Area

Table 47: Shinva. Products Portfolio

Table 48: BELIMED Basic Information And Sales Area

Table 49: BELIMED. Products Portfolio

Table 50: Nuova SB System Basic Information And Sales Area

Table 51: Nuova SB System. Products Portfolio

Table 52: Global Market Value (USD Million) (2025-2032) By Application

Table 53: Global Market Share (%) By Application (2032)

Table 54: Global Market Value (USD Million) (2025-2032) By Types

Table 55: Global Market Share (%) By Types (2032)

Table 56: Global Endoscope Reprocessing Medical Device Market Value (USD Million) By Region

Table 57: Global Endoscope Reprocessing Medical Device Market Share (%) By Region (2025-2032)

Table 58: North America Market Value (USD Million) (2025-2032) By Country

Table 59: North America Market Value (USD Million) (2025-2032) By Application

Table 60: North America Market Value (USD Million) (2025-2032) By Types

Table 61: Europe Market Value (USD Million) (2025-2032) By Country

Table 62: Europe Market Value (USD Million) (2025-2032) By Application

Table 63: Europe Market Value (USD Million) (2025-2032) By Types

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 65: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 67: South America Market Value (USD Million) (2025-2032) By Country

Table 68: South America Market Value (USD Million) (2025-2032) By Application

Table 69: South America Market Value (USD Million) (2025-2032) By Types

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 71: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 73: Research Programs/Design For This Report

Table 74: Key Data Information From Secondary Sources

Table 75: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Endoscope Reprocessing Medical Device Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	531.00 million
Revenue forecast in 2033	926.09 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Detro Healthcare; Olympus; STERIS; Getinge; PENTAX Medical (Hoya); Ecolab; Wassenburg Medical; SciCan; Shinva; BELIMED; Nuova SB System
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options